Using the lows as a stop, I could see this stock slowly working its way to the upper lateral trend line and eventually breaking out.

FORBES: Trading the President's Speech

The stock recently broke above a lateral and descending trend line going back several months.

FORBES: What's the Trade? Consol Long

Today Biogen Idec (BIIB) reported top-line results of EMPOWER, a Phase 3 trial investigating dexpramipexole in people with amyotrophic lateral sclerosis (ALS).

FORBES: Biogen Idec ALS Drug Fails